Influence of injection time in DCE-MRI in patients with prostate cancer

Influence of injection time in DCE-MRI in patients with prostate cancer - influence of injection time

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37313

Enrollment

Registered

2012-08-23

Start date

2013-03-20

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: biopsy proven prostate cancer able to undergo MRI

Exclusion criteria

Exclusion criteria: • • Contra-indications for a MRI exam according to the standard protocol for the screening of patients with prostate cancer. • GFR

Design outcomes

Primary

Measure	Time frame
Establish the influence of injection time of kinetic tracer parameters, determined with Dynamic Constrast-Enhanced MRI of the prostate.	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results